The WAO 2020 consensus document highlights the benefits of PAMD@ for patients with food allergies, food protein-induced enterocolitis syndrome, respiratory sensitization to food-pollen or inhalant food syndrome [49,86]; it allows individual patterns of IgE sensitization to be determined through the analysis of a single allergen molecules (recombinant or purified native) over complex allergenic extracts [49]. The gene discussed is IGHE; the disease is food allergy.